Company patents
ICU MEDICAL, INC.
ICU Medical, Inc. maintains a strong focus on Drug Delivery Devices, which constitutes 76.1% of its portfolio, yet saw a significant decline of 59.4% in 2026 so far, indicating a potential shift in priority. Surprisingly, despite its core medical device business, the company has shown an emerging focus in Medical Diagnostics & Surgery, with a rapid 66.7% year-over-year growth in 2025, suggesting an expansion into related medical fields.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
280 US filings (since 2023) · 12 categories · 14 themes
Devices and adapters that enable the sterile and secure transfer of liquids, such as medications or diluents, between containers (vials, syringes, IV bags) while minimizing exposure to contaminants or air.
Systems that integrate digital technology, sensors, or connectivity to monitor, track, or automate aspects of medication administration, often providing data feedback, personalized recommendations, or secure logging.
Devices or systems designed to precisely measure and deliver specific doses of medication, often incorporating automated mechanisms, dose-limiting features, or hands-free operation.
Mechanical or electromechanical systems designed for precise, often self-administered, delivery of medicaments, including features for dose setting, needle insertion/retraction, and safety mechanisms to prevent premature activation.
Minimally invasive medical devices, typically flexible tubes, inserted into body lumens to deliver substances, remove obstructions, or perform localized treatments like ablation, dialysis, or drainage.
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Devices that assist in the physical modification or mixing of medications prior to administration, such as crushing solid drugs, cutting pills, reconstituting lyophilized products, or extracting from other devices.
Systems and methods for non-invasive or minimally invasive collection and analysis of physiological data (e.g., blood pressure, electrolytes, genetic markers, B cell repertoire) to assess patient health status, screen for conditions, or aid in diagnosis.
Systems and methods for securely and reliably delivering, installing, and managing software or firmware updates to distributed or embedded devices, often considering network conditions, resource constraints, or storage repartitioning.
Digital platforms and systems that deliver tailored therapeutic interventions, guidance, or recommendations to patients based on their individual health data, biometric feedback, and computational models (e.g., AI/ML, physiological simulations).
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
Hollow-fiber and flat-sheet membranes for blood purification, hemodialysis, hemofiltration, and related extracorporeal therapies.
Development of devices and methods for non-invasive or minimally invasive collection and analysis of physiological data, often from wearable sensors, to monitor health, activity, or specific conditions.
Techniques and systems designed to monitor network health, diagnose issues, optimize traffic flow, and ensure continuous operation and reduced downtime in complex network environments, including cloud and storage area networks.
Patents
Showing 1-10 of 423